Increased circulating regulatory T cells (CD4+CD25+CD127-) contribute to lymphocyte anergy in septic shock patients

被引:325
作者
Venet, Fabienne [2 ]
Chung, Chun-Shiang [2 ]
Kherouf, Hakim [1 ]
Geeraert, Anne [1 ]
Malcus, Chistophe [1 ]
Poitevin, Francoise [1 ]
Bohe, Julien [3 ]
Lepape, Alain [3 ]
Ayala, Alfred [2 ]
Monneret, Guillaume [1 ]
机构
[1] Hosp Civils Lyon, Hop Edouard Herriot, Immunol Lab, Flow Cytometry Unit, F-69437 Lyon 03, France
[2] Brown Univ, Rhode Isl Hosp, Div Surg Res, Providence, RI 02903 USA
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Intens Care Units, Lyon, France
关键词
Septic shock; Anergy; CD4(+)CD25(+); CD127; Regulatory T cells; Foxp3; DELAYED-HYPERSENSITIVITY; RECEPTOR EXPRESSION; SEVERE SEPSIS; FOXP3; APOPTOSIS; EPIDEMIOLOGY; LYMPHOKINES; MORTALITY; FAILURE; COSTS;
D O I
10.1007/s00134-008-1337-8
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Purpose: Sepsis syndrome represents the leading cause of death in intensive care unit. Patients present features consistent with a decline in immune responsiveness potentially contributing to mortality. We investigated whether CD4(+)CD25(+) regulatory T cells (Treg) participate in the induction of lymphocyte anergy after sepsis. Method: Observational study in septic shock patients and experimental study in mice. Results: We took advantage of the recently described flow cytometric gating strategy using the measurement of CD25 and CD127 expressions for monitoring Treg (CD4(+)CD25(+)CD127(-)Foxp3(+)). In patients the increased circulating Treg percentage significantly correlated with a decreased lymphoproliferative response. In a murine model of sepsis mimicking these observations, the ex vivo downregulation of Foxp3 expression using siRNA was associated with a restoration of this response. Conclusion: The relative increase in circulating Treg might play a role in lymphocyte anergy described after septic shock and represent a standardizable surrogate marker of declining proliferative capacity after sepsis.
引用
收藏
页码:678 / 686
页数:9
相关论文
共 47 条
[1]
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[2]
Human CD4+CD25+ regulatory T cells [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :89-97
[3]
Human regulatory T cells and their role in autoimmune disease [J].
Baecher-Allan, Clare ;
Hafler, David A. .
IMMUNOLOGICAL REVIEWS, 2006, 212 :203-216
[4]
MHC class II expression identifies functionally distinct human regulatory T cells [J].
Baecher-Allan, Clare ;
Wolf, Elizabeth ;
Haller, David A. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :4622-4631
[5]
Negative signaling contributes to T-cell anergy in trauma patients [J].
Bandyopadhyay, Gautam ;
De, Asit ;
Laudanski, Krzysztof ;
Li, Fang ;
Lentz, Christopher ;
Bankey, Paul ;
Miller-Graziano, Carol .
CRITICAL CARE MEDICINE, 2007, 35 (03) :794-801
[6]
Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells [J].
Banham, Alison H. .
TRENDS IN IMMUNOLOGY, 2006, 27 (12) :541-544
[7]
Modulation of Fas-dependent apoptosis: A dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells [J].
Banz, A ;
Pontoux, C ;
Papiernik, M .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :750-757
[8]
Regulatory T cells and infection: a dangerous necessity [J].
Belkaid, Yasmine .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (11) :875-888
[9]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[10]
EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units [J].
Brun-Buisson, C ;
Meshaka, P ;
Pinton, P ;
Vallet, B ;
Rodie-Talbere, P ;
Zahar, JR .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :580-588